Shenzhen China Resources Gosun Pharmaceuticals

CR Gosun, a subsidiary of China Resources Pharmaceutical Group, is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of anti-infective medications. The company is recognized as one of the largest production bases for cephalosporin antibiotics in China, maintaining high standards with EU-GMP and domestic GMP certifications. Its product portfolio primarily focuses on high-end intravenous antibiotics, including various generations of cephalosporins and carbapenems. CR Gosun operates integrated facilities in Shenzhen that cover the entire value chain from active pharmaceutical ingredient (API) synthesis to finished dosage form production. The company is increasingly investing in R&D to transition from generic manufacturing toward innovative drug development in the anti-infective and respiratory therapeutic areas.